Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
about
Determinants of early life immune responses to RSV infectionInfluenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methodsAge at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine ModelAdjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.
P2860
Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Vaccines against respiratory v ...... opportunities and challenges.
@en
type
label
Vaccines against respiratory v ...... opportunities and challenges.
@en
prefLabel
Vaccines against respiratory v ...... opportunities and challenges.
@en
P2860
P356
P1476
Vaccines against respiratory v ...... opportunities and challenges.
@en
P2093
Martha A Alexander-Miller
P2860
P304
P356
10.4049/JIMMUNOL.1401410
P407
P577
2014-12-01T00:00:00Z